Same quality-control standards as your prescriptions
Even a cursory read through the established facts is pretty shocking
We included 25,134 participants aged 45 years (6303 cases and 18,831 matched controls) with hypertension and at least one year of AHM therapy between January 1, 2011, and December 31, 2020
66 (Tables 1 and 2) Current GLP-1RAs GLP-1RAs are synthetic protein preparations that have partial or complete amino acid sequence homology with GLP-1 found in the body, are not easily degraded, have longer half-lives and have stronger biological activity
Strong sourcing relationships often become an important component of long-term laboratory planning
These peptides have NEVER been approved, so there's no "label" to go off of